OP-4 Characterising mirvetuximab-induced ocular surface disease
Crossref DOI link: https://doi.org/10.1136/bmjophth-2024-BCM.4
Published Online: 2024-04-12
Published Print: 2024-04
Update policy: https://doi.org/10.1136/crossmarkpolicy
Neo, Yan Ning
Ahmad, Sajjad
License valid from 2024-04-12
